Glen Harbor Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.13M | Hold |
14,994
| – | – | 0.04% | 316 |
|
|
2019
Q2 | $1.88M | Hold |
14,994
| – | – | 0.04% | 348 |
|
|
2019
Q1 | $1.65M | Hold |
14,994
| – | – | 0.04% | 350 |
|
|
2018
Q4 | $1.47M | Buy |
14,994
+442
| +3% | +$43.3K | 0.04% | 347 |
|
|
2018
Q3 | $1.8M | Buy |
14,552
+2,720
| +23% | +$336K | 0.04% | 354 |
|
|
2018
Q2 | $1.18M | Hold |
11,832
| – | – | 0.03% | 399 |
|
|
2018
Q1 | $1.05M | Hold |
11,832
| – | – | 0.02% | 406 |
|
|
2017
Q4 | $1.17M | Buy |
11,832
+1,836
| +18% | +$181K | 0.03% | 399 |
|
|
2017
Q3 | $962K | Buy |
9,996
+1,394
| +16% | +$134K | 0.02% | 416 |
|
|
2017
Q2 | $813K | Buy |
8,602
+3,366
| +64% | +$318K | 0.02% | 470 |
|
|
2017
Q1 | $427K | Buy |
5,236
+782
| +18% | +$63.8K | 0.01% | 595 |
|
|
2016
Q4 | $378K | Buy |
+4,454
| New | +$378K | 0.01% | 573 |
|